Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Drug Name | Invikafusp alfa |
| Trade Name | |
| Synonyms | STAR-0602|STAR 0602|STAR0602 |
| Drug Descriptions |
Invikafusp alfa is a bifunctional antibody-fusion molecule comprising an antibody that targets Vbeta6 and Vbeta10 T-cell receptors fused to IL-2, which potentially enhances antitumor immune response and inhibits tumor growth (PMID: 38019931). |
| DrugClasses | |
| CAS Registry Number | 2894138-60-2 |
| NCIT ID | C206925 |
| Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
|---|---|---|---|
| Invikafusp alfa | Invikafusp alfa | 0 | 1 |
| Invikafusp alfa + Sacituzumab govitecan-hziy | Invikafusp alfa Sacituzumab govitecan-hziy | 0 | 1 |